Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological studyJin Lü, Ning Zhang, Zhengjing Huang et al.|The Lancet Psychiatry|2021Cited by 826
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in ChinaChuan Shi, Xin Yu, Lan Kang et al.|Schizophrenia Research|2015Cited by 320
What is the optimal neuropsychological test battery for schizophrenia in China?Chuan Shi, Xin Yu, Lan Kang et al.|Schizophrenia Research|2019Cited by 34
Sp1 Targeted PARP1 Inhibition Protects Cardiomyocytes From Myocardial Ischemia–Reperfusion Injury via Downregulation of AutophagyYifeng Xu, Hongli Li|Frontiers in Cell and Developmental Biology|2021Cited by 27
Improvement in social and cognitive functioning associated with paliperidone extended-release treatment in patients with schizophrenia: a 24-week, single arm, open-label studyChuan Shi, Xin Yu, Shuqiao Yao Shuqiao et al.|Neuropsychiatric Disease and Treatment|2016Cited by 6